Dibekacin


Generic Medicine Info
Contraindications
Pregnancy; hypersensitivity; known or suspected perforation of the eardrum (topical application into the ear).
Special Precautions
Myasthenia gravis; regular assessment of auditory and renal function is necessary in patients with additional risk factors. Monitoring is important in patients on high doses or prolonged courses, impaired renal function; infants, elderly, obese, cystic fibrosis.
Adverse Reactions
Ototoxicity; nephrotoxicity; acute renal failure, decreased glomerular filtration rate; electrolyte disturbances; respiratory depression; muscular paralysis; hypersensitivity reactions; atrophy or fat necrosis at Inj sites; cross-sensitivity with other aminoglycosides.
Drug Interactions
Other nephrotoxic drugs e.g. vancomycin, cephalosphorins, ciclosporin, cisplatin and fludarabine; potentially ototoxic drugs e.g. ethacrynic acid, furosemide; neuromuscular-blocking agents; general anaesthetics; opioids; β-lactams; dimenhydrinate.
CIMS Class
ATC Classification
J01GB09 - dibekacin ; Belongs to the class of other aminoglycosides. Used in the systemic treatment of infections.
Disclaimer: This information is independently developed by CIMS based on dibekacin from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in